Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Betafectin data

ABTI (Worcester, Mass.) announced results of its second Phase II study at the Surgical Infectious Society meeting in Toronto.

Read the full 195 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE